Cargando…

Management of Condyloma Acuminata in Pregnancy: A Review

No clear guidelines are available for the management of pregnant women with condyloma acuminata, a human papillomavirus–associated benign neoplasm that develops in the genital tract. We performed a systematic review to gain a better understanding of the management of condyloma acuminata during pregn...

Descripción completa

Detalles Bibliográficos
Autores principales: Sugai, Shunya, Nishijima, Koji, Enomoto, Takayuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8132606/
https://www.ncbi.nlm.nih.gov/pubmed/33093288
http://dx.doi.org/10.1097/OLQ.0000000000001322
_version_ 1783694940893609984
author Sugai, Shunya
Nishijima, Koji
Enomoto, Takayuki
author_facet Sugai, Shunya
Nishijima, Koji
Enomoto, Takayuki
author_sort Sugai, Shunya
collection PubMed
description No clear guidelines are available for the management of pregnant women with condyloma acuminata, a human papillomavirus–associated benign neoplasm that develops in the genital tract. We performed a systematic review to gain a better understanding of the management of condyloma acuminata during pregnancy. In this review, we mainly focused on treatments. We searched PubMed, Google Scholar, and Web of Science to identify studies on the treatment of condyloma acuminata during pregnancy. Thirty articles met the inclusion criteria. The treatment methods described in the literature were laser therapy, cryotherapy, imiquimod, photodynamic therapy, trichloroacetic acid, and local hyperthermia. The most effective treatment remains unclear. Various factors must be considered when deciding how to treat. Based on our assessment of the literature, we recommend cryotherapy as the first-choice treatment and laser therapy as the second-choice treatment. Imiquimod can be considered in cases such as extensive condyloma acuminata that is not easily treated by cryotherapy or laser therapy. In such cases, sufficient informed consent must be obtained from the patient. Cryotherapy, laser therapy, and imiquimod have been administered during all 3 trimesters with no severe adverse effects, but we cautiously recommend reserving laser therapy until the third trimester because of the lower risk of recurrence before delivery. There are still many unclear points regarding the management of condyloma in pregnancy, and further research is needed.
format Online
Article
Text
id pubmed-8132606
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-81326062021-05-20 Management of Condyloma Acuminata in Pregnancy: A Review Sugai, Shunya Nishijima, Koji Enomoto, Takayuki Sex Transm Dis Reviews No clear guidelines are available for the management of pregnant women with condyloma acuminata, a human papillomavirus–associated benign neoplasm that develops in the genital tract. We performed a systematic review to gain a better understanding of the management of condyloma acuminata during pregnancy. In this review, we mainly focused on treatments. We searched PubMed, Google Scholar, and Web of Science to identify studies on the treatment of condyloma acuminata during pregnancy. Thirty articles met the inclusion criteria. The treatment methods described in the literature were laser therapy, cryotherapy, imiquimod, photodynamic therapy, trichloroacetic acid, and local hyperthermia. The most effective treatment remains unclear. Various factors must be considered when deciding how to treat. Based on our assessment of the literature, we recommend cryotherapy as the first-choice treatment and laser therapy as the second-choice treatment. Imiquimod can be considered in cases such as extensive condyloma acuminata that is not easily treated by cryotherapy or laser therapy. In such cases, sufficient informed consent must be obtained from the patient. Cryotherapy, laser therapy, and imiquimod have been administered during all 3 trimesters with no severe adverse effects, but we cautiously recommend reserving laser therapy until the third trimester because of the lower risk of recurrence before delivery. There are still many unclear points regarding the management of condyloma in pregnancy, and further research is needed. Lippincott Williams & Wilkins 2021-06 2020-10-22 /pmc/articles/PMC8132606/ /pubmed/33093288 http://dx.doi.org/10.1097/OLQ.0000000000001322 Text en Copyright © 2020 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Sexually Transmitted Diseases Association. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Reviews
Sugai, Shunya
Nishijima, Koji
Enomoto, Takayuki
Management of Condyloma Acuminata in Pregnancy: A Review
title Management of Condyloma Acuminata in Pregnancy: A Review
title_full Management of Condyloma Acuminata in Pregnancy: A Review
title_fullStr Management of Condyloma Acuminata in Pregnancy: A Review
title_full_unstemmed Management of Condyloma Acuminata in Pregnancy: A Review
title_short Management of Condyloma Acuminata in Pregnancy: A Review
title_sort management of condyloma acuminata in pregnancy: a review
topic Reviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8132606/
https://www.ncbi.nlm.nih.gov/pubmed/33093288
http://dx.doi.org/10.1097/OLQ.0000000000001322
work_keys_str_mv AT sugaishunya managementofcondylomaacuminatainpregnancyareview
AT nishijimakoji managementofcondylomaacuminatainpregnancyareview
AT enomototakayuki managementofcondylomaacuminatainpregnancyareview